A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin

por Thabit, Abrar K., Alam, M. Jahangir, Khaleduzzaman, Mohammed, Garey, Kevin W., Nicolau, David P.
Publicado 2016

Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection

por Bassères, Eugénie, Endres, Bradley T., Khaleduzzaman, Mohammed, Miraftabi, Faranak, Alam, M. Jahangir, Vickers, Richard J., Garey, Kevin W.
Publicado 2016

Community Environmental Contamination of Toxigenic Clostridium difficile

por Alam, M Jahangir, Walk, Seth T., Endres, Bradley T., Basseres, Eugenie, Khaleduzzaman, Mohammed, Amadio, Jonathan, Musick, William L., Christensen, Jennifer L., Kuo, Julie, Atmar, Robert L., Garey, Kevin W.
Publicado 2017